Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jul 27;18(7):e0288161. doi: 10.1371/journal.pone.0288161

Using whole blood cultures in interferon gamma release assays to detect Mycobacterium tuberculosis complex infection in Asian elephants (Elephas maximus)

Chitsuda Pongma 1,2, Songkiat Songthammanuphap 3, Songchan Puthong 4, Anumart Buakeaw 4, Therdsak Prammananan 5, Saradee Warit 5, Wanlaya Tipkantha 6, Erngsiri Kaewkhunjob 6, Waleemas Jairak 6, Piyaporn Kongmakee 6, Choenkwan Pabutta 7,¤, Supaphen Sripiboon 8, Wandee Yindeeyoungyeon 5,*,#, Tanapat Palaga 2,3,*,#
Editor: Harish Chandra9
PMCID: PMC10374124  PMID: 37498897

Abstract

Elephants are susceptible to Mycobacterium tuberculosis (M. tb) complex (MTBC) infections. Diagnosis of tuberculosis (TB) in elephants is difficult, and most approaches used for human TB diagnosis are not applicable. An interferon gamma release assay (IGRA) to diagnose TB in Asian elephants (Elephas maximus) using peripheral blood mononuclear cells (PBMCs) has been previously developed. Although the assay is shown to be valid in determining MTBC infection status, the laborious PBMC isolation process makes it difficult to use. In this study, we simplified the method by using whole blood cultures (WC) as the starting material. Using PBMC cultures for IGRA, the MTBC infection status of 15 elephants was first confirmed. Among these animals, one has been previously confirmed for M. tb infection by both TB culture and PCR and the other was confirmed for MTBC infection in this study by droplet digital PCR (ddPCR) method. WC for IGRA consisted of an unstimulated sample, a mitogen stimulated sample, and sample stimulated with recombinant M. tb antigens, ESAT6 and CFP10. Using WC for IGRA in the 15 enrolled elephants, the results showed that 7 out of 15 samples yielded MTBC infection positive status that were completely concordant with those from the results using PBMCs. To test this method, WC for IGRA were applied in another elephant cohort of 9 elephants. The results from this cohort revealed a perfect match between the results from PBMC and WC. Responses to ESAT6 or CFP10 by PBMC and WC were not completely concordant, arguing for the use of at least two M. tb antigens for stimulation. Given the ease of sample handling, smaller blood sample volumes and equivalent efficacy relative to the PBMC approach, using WC for IGRA provides a novel, rapid, and user-friendly TB diagnostic method for determining the MTBC infection in elephants.

Introduction

Tuberculosis (TB) is a potentially serious infectious disease that affects humans and animals. It is caused by the Mycobacterium tuberculosis complex (MTBC), especially Mycobacterium tuberculosis (M. tb), and spreads from person to person by airborne transmission [1]. In addition to human-to-human transmission, M. tb can be transmitted from animals to humans and vice versa. The main cause of TB infections in animals consists of transmission by close prolonged contact with individuals or animals with active TB [2]. MTBC infects a wide variety of animal hosts, including nonhuman primates and captive and wild animals, such as cattle, rhinoceros, wild dogs, and elephants [1, 3, 4]. In various countries, including Thailand, captive Asian elephants (Elephas maximus), in particular, often have prolonged periods of close contact with humans and are prone to infection with M. tb, as first reported in 1875 [2]. There is also a report of fatal TB in a free-ranging African elephant in a region with a high human TB burden [5]. TB in elephants presents as a chronic infection and often does not exhibit obvious clinical symptoms until the disease reaches the active stage [6]. The symptoms in infected elephants include fatigue, labored breathing, trunk discharges, and weight loss, followed by death [7].

Owing to their large size and thick skin, diagnostic tests for TB in elephants are difficult to perform, and the regular techniques used in humans, such as chest X-rays and tuberculin skin tests, are not applicable [8]. As a result, an accurate and user-friendly diagnostic platform for elephant TB that covers all stages of infection is urgently needed. Currently, bacterial cultures from trunk washes and affected tissues at necropsy are recommended as the current gold standard methods for TB diagnoses. However, such methods have various limitations, including difficulty in obtaining samples, low sensitivity, and the limitation of detection only in the active TB stage. As an alternative approach, other immunological indicators of TB infections, such as antibody detection and antigen-specific interferon release assays, have been investigated [812].

M. tb is an intracellular pathogen, and cell-mediated immune responses (CMIR) are elicited early after infection and are considered to mainly contribute to the control of infection [13]. Interferon gamma (IFN©) is a key cytokine that is produced mainly by T helper type 1, cytotoxic T lymphocytes, and natural killer cells during mycobacterial infections [14]. A test to detect memory T cells that are specific to TB antigens can be implemented by using an IFN© release assay (IGRA). This method uses defined TB antigen stimulation of lymphocytes, followed by measurements of IFNγ release using an enzyme-linked immunosorbent assay (ELISA). IGRA is currently used for human TB diagnoses, which uses whole blood samples for stimulation by antigens within the region of difference 1 (RD1) of M. tb. These antigens are peptides derived from early secreted antigenic target 6 kDa (ESAT6) and culture filtrate protein 10 kDa (CFP10), which are not present in the vaccine strain, Bacillus Calmette-Guérin (BCG). These antigens are potent inducers of CMIR, even in an in vitro setting, which enables detection of IFN© secretion [15, 16].

Previous studies have demonstrated that IGRAs can be used as an alternative tool to diagnose TB in Asian and African elephants [12, 17, 18]. In our previous report, we developed an in-house IGRA to detect M. tb infections that can distinguish between naïve, nontuberculous mycobacteria (NTM) infections and MTBC infections in Asian elephants with the world’s largest sample sizes of more than 60 elephants [12]. The protocol is relatively accurate in detecting MTBC infections, but there are some disadvantages in using peripheral blood mononuclear cells (PBMCs) for measuring the response to stimulating antigens. Although using PBMCs helps in normalizing the discrepancies in white blood cell counts in samples, isolating PBMCs is time-consuming and requires a tissue culture facility with skilled technicians [12].

Therefore, the aim of this study was to develop an IGRA-based TB diagnostic platform for use in elephants using whole blood cultures. The results obtained from this study will lead to a user-friendly IGRA-based elephant TB diagnosis platform.

Materials and methods

Blood samples from Asian elephants

Blood samples (n = 22) were collected from captive Asian elephants (E. maximus) in Thailand (20 females and 2 males, aged 3–80 years). The elephants were registered under the health checkup program by the Zoological Park Organization and National Elephant Institute. Whole blood samples were collected periodically in heparinized tubes (BD Vacutainer, Becton Dickinson, USA) and processed within 24 hr.

For testing IGRA in a cohort with unknown M. tb infection status, blood samples (n = 9) were collected from another captive elephant cohort (female n = 7 male n = 2, aged 6–48 years). Blood samples were collected in heparinized tubes (BD Vacutainer, Becton Dickinson, USA) and processed within 24 hr. Blood samples were subjected for peripheral blood mononuclear cells (PBMCs) isolation or used as whole blood for IGRA as described below.

All procedures for collecting blood samples were approved by the Institutional Animal Care and Use Committee (IACUC) of the Zoological Park Organization of Thailand and the National Center for Genetic Engineering and Biotechnology (BT-Animal 1/2562) and were performed according to the IACUC guidelines. Detailed information on elephants enrolled in this study is summarized in S1S3 Tables.

Isolation of PBMCs

PBMCs were isolated by using the density centrifugation method with Ficoll-Paque Premium media solution (GE Healthcare, USA) as previously described [12]. Briefly, blood samples were centrifuged at 400 x g to obtain leukocytes (buffy coat). The separated leukocytes were diluted with phosphate-buffered saline (PBS) to adjust the volume to 10 ml to resuspend the cell pellets. After dilution, the diluted cell suspensions (10 ml) were carefully overlaid onto 5 ml of Ficoll-Paque Premium media solution (GE Healthcare) in 15-ml centrifuge tubes, and the samples were centrifuged at 400 x g for 40 min at 20°C without breaking. The mononuclear cells that formed a layer between the plasma (upper layer) and Ficoll-Paque Premium media were collected into new centrifuge tubes and washed. The washing step was repeated three times before resuspending the cell pellets in complete RPMI 1640 media supplemented with 0.05 mM β-mercaptoethanol.

Reagents

Recombinant ESAT6 and CFP10 were produced by using Escherichia coli and purified by affinity column chromatography as previously reported [19]. Recombinant eIFN© was produced in Escherichia coli transformed with an expression plasmid harboring the eIFN© gene obtained from a female Asian elephant. Monoclonal antibodies to detect eIFN© were prepared from hybridomas obtained by immunizing mice with recombinant eIFN© [12].

Stimulating PBMCs with mitogens or antigens

PBMCs were seeded at 1 × 105 cells/well in a 96-well U-bottom plate (Thermo Fisher Scientific, USA) in a final volume of 150 μl. Cells were stimulated with concanavalin A (ConA) (10 μg/ml) (Sigma Aldrich, USA), recombinant ESAT6 and/or CFP10 (10 μg/ml each) for 72 h in a CO2 incubator. After stimulation, culture supernatants were collected and subjected to sandwich ELISA to measure eIFN© as described below.

Whole blood culture for IGRA

Blood samples were collected from each elephant into heparinized tubes (BD Vacutainer). One milliliter of blood from each heparinized tube was transferred into 5-ml polypropylene tubes (Falcon A Corning Brand, USA). Mitogens (pokeweed mitogen (PWM) (10 μg/ml), ConA (10 μg/ml), PWM with ConA (10 μg/ml each)) or specific TB antigens (recombinant ESAT6 (20 μg/ml) and CFP10 (20 μg/ml)) were added at the indicated concentrations to stimulate immune cells in whole blood. The tubes were gently mixed by shaking for 10 times, and incubation was carried out at 37°C for 24 hr. After 24 hr of stimulation, the blood tubes were centrifuged, and plasma samples were harvested to detect eIFN© by sandwich ELISA as described for the PBMC cultures.

Sandwich ELISA to detect eIFNγ

All reagents used for sandwich ELISA were prepared according to previously described procedures [12]. The 96-well ELISA plates were coated with goat anti-rabbit IgG Fc fragment-specific antibody (Jackson ImmunoResearch, USA). After blocking with 10% FBS in PBS, the plates were washed, and diluted rabbit sera specific to eIFNγ were added to the wells. This step was followed by adding standard eIFNγ (0–10 ng/ml), samples from the PBMC culture supernatants or plasma from whole blood cultures to the plates. Plates were kept overnight at 4°C. Plates were washed the following day before a mouse monoclonal IgG antibody specific to eIFNγ (0.5 μg/ml) was added. The plates were incubated at 37°C for 1 hr, and goat anti-mouse IgG (Sigma‒Aldrich) conjugated with peroxidase (1:10000) was added, followed by TMB substrate solution. The reaction was stopped with 1 M H2SO4, and the absorbances at 450 nm were measured by a microplate reader (Multiskan FC, Thermo Fisher Scientific, USA).

The limit of detection (LOD) for the standard curve was calculated using the following formula: LOD = B0+3SD, where B0 is the average absorbance at 450 nm of the blank samples and SD is the standard deviation of the blank samples. Specific M. tb antigens stimulated -samples that yielded eIFNγ higher than B0+3SD and greater than the lowest concentration of the standard curve were considered positive results.

Results

Status of MTBC infections in the enrolled elephants using PBMC IGRA

To confirm the MTBC infection status in the cohort of elephants enrolled in this study, we applied IGRA using isolated PBMCs as described previously [12]. Among these elephants, elephant No. 2 has been previously diagnosed as M. tb infection by both TB culture and PCR from trunk wash [20] and No.1 has been confirmed of MTBC infection by ddPCR from trunk swab (this study, S1 File). Freshly isolated PBMCs were cultured in the presence of purified recombinant ESAT6 or CFP10 or mitogen ConA for 72 hr. The culture supernatants were harvested and subjected to ELISA to determine the eIFNγ concentrations (Fig 1A). The eIFNγ concentrations obtained from each elephant are summarized in Fig 1B. Based on the interpretation criteria described by Songthammanuphap et al. with some modifications, the MTBC infection status was divided into 2 groups: 1) MTBC infection negative, 2) MTBC infection positive. The infection status is depicted as color-coded dots in Fig 1B. The results of the infection status of the 15 elephants are summarized and presented as a heatmap in Fig 2.

Fig 1. eIFNγ amounts released after stimulation of elephant PBMCs by mitogens and antigens.

Fig 1

(A) Schematic representation of PBMC stimulation for IGRA. (B) The eIFN© levels in culture supernatants of PBMCs stimulated by MTBC antigens as indicated in (A). The eIFN© levels were measured by sandwich ELISA. Different color-coded dots represent individual elephants with MTBC infection statuses determined by using the criteria described in previous reports [12].

Fig 2. Summary of MTBC infection status determined by PBMC cultures for IGRA.

Fig 2

The responses of PBMCs against M. tb antigens by eIFN© secretion were used to determine MTBC infection status. The results are summarized in a heatmap, where an MTBC positive status is shown by red boxes, MTBC infection negative status is shown by green boxes, and infection indeterminate status is shown by yellow boxes.

Among the 15 elephants tested, 8 elephants were negative for MTBC infection whereas 7 elephants showed MTBC positive results. Among the ones tested positive for MTBC infection, elephant No. 1 was diagnosed with M. tb infection by ddPCR in this study and elephant No. 2 has been previously diagnosed with M. tb infection by both PCR and TB culture. Interestingly, sample No. 2 and 3 showed negative response to ESAT6 stimulation but exhibited a positive response to CFP10 and, thus, considered MTBC positive.

Testing mitogens for whole blood culture and detection of eIFNγ

In our previous elephant PBMC culture study, ConA and PWM were tested for their ability to stimulate secretion of eIFN©, and the results showed that ConA was superior to PWM [12]. Therefore, ConA was chosen as a mitogen as the positive control for PBMC stimulation. To select a suitable mitogen for whole blood cultures, blood samples from 10 healthy elephants were subjected to mitogen stimulation, and the eIFN© concentrations were determined. As shown in Fig 3A, PWM (10 μg/ml) alone or PWM in combination with ConA (10 μg/ml each) induced significantly higher eIFN© secretion levels than the unstimulated or ConA-treated samples. To our surprise, ConA alone did not induce detectasble amounts of eIFN©, in contrast to those in PBMC cultures. Therefore, in whole blood cultures for IGRA, PWM was chosen as a positive control to stimulate eIFN© secretion.

Fig 3. Schematic representation of whole blood cultures for IGRA.

Fig 3

(A) Amounts of eIFNγ produced from cells in whole blood cultures after stimulation with different mitogens for 24 h (n = 10). **** p value ≤ 0.0001, and ns indicates not statistically significant with a p value > 0.05. (B) Schematic workflow for whole blood cultures and IGRA for MTBC detection. The figure is created by the authors with BioRender.com.

Protocol for whole blood cultures for IGRA and interpretation of the results

To establish the whole blood culture for IGRA, the overall protocol is summarized in Fig 3B. Venous blood was collected in heparinized tubes with at least 4 ml per animal and used within 24 hr of collection. Blood was aliquoted into 4 polypropylene tubes (1 ml each). A negative control tube was left unstimulated (NIL), while PWM (10 μg/ml) was added to the mitogen positive control tube. For the specific TB antigens, recombinant ESAT6 (20 μg/ml) was added to the TB1 tube, and recombinant CFP10 (20 μg/ml) was added to the TB2 tube. After thoroughly mixing the samples by gentle shaking, the tubes were incubated at 37°C for 24 hr. Plasma samples were harvested by centrifugation and used as samples for ELISA to detect eIFN©. The results obtained from ELISA were calculated to obtain the eIFN© concentrations. When the absorbance at 450 nm from ELISA fell between the LOD and lowest concentration of the standard curve, the samples were considered indeterminate.

The flowchart in Fig 4 depicts the interpretation of the eIFN©secretion results and MTBC infection status. First, the value of the mitogen-stimulated positive control must be higher than that of the negative control. If this is not the case, the result is determined to be uninterpretable. For the samples that show the expected results of the positive control tubes, the results from the samples with specific TB antigen stimulation will be evaluated. If both TB1 and TB2 yield results similar to the negative control, the infection status will be determined as MTBC infection negative. If at least one of the TB1 or TB2 tubes (ESAT6 and CFP10) shows a response higher than that of the negative control, the status will be interpreted as MTBC infection positive. If at both TB1 and TB2 yields an indeterminate readout, the status will be marked as indeterminate.

Fig 4. Flowchart detailing the interpretation of results from whole blood culture IGRAs.

Fig 4

Based on the IGRA results, the interpretation of infection status is conducted by following steps 1–6. The interpretations results include uninterpreted, MTBC infection negative, MTBC infection positive and MTBC infection indeterminate.

Whole blood cultures for IGRA to determine MTBC infection status

Using the method and interpretation described above, the 15 enrolled elephants with determined MTBC infection statuses were subjected to whole blood cultures for IGRAs. The eIFN© concentrations obtained from PBMC cultures and whole blood cultures were compared and the results are shown in Fig 5A. The color-coded dots represented the MTBC infection status interpreted by the criteria described by Songthammanuphap et al. [12] for PBMC or those described above for WC. All but two whole blood culture samples yielded higher eIFN© concentrations than the PBMC cultures in the mitogen-stimulating positive control. Similarly, in ESAT6- and CFP10-stimulated conditions, all but two whole blood culture samples showed higher eIFN© concentrations than the PBMC cultures. In the TB1 (ESAT6) tubes, five samples (No. 2, 3, 5, 6, 15) yielded conflicting results between the whole blood cultures and PBMC cultures. In the TB2 (CFP10) tubes, all samples yielded consistent results between PBMC and WC cultures.

Fig 5. Results of eIFNγ concentrations obtained by PBMC cultures IGRA (PC) and whole blood cultures IGRA (WC) and summary of result interpretations.

Fig 5

(A) The results are presented as the eIFN© concentrations with comparisons between PBMC assays or whole blood culture assays at the individual level. The MTBC infection statuses were simplified to infection negative (green) or infection positive (red). (B) Fifteen elephant samples were subjected to PBMC cultures for IGRA in parallel with whole blood cultures for IGRA. The results obtained from each assay were interpreted based on the criteria described by Songthammaniphap et al. and above [12]. The interpretations are presented as a heatmap.

Based on the IGRA interpretation described in Fig 4, the results of the two IGRA approaches are summarized as a heatmap in Fig 5B. Among the tested elephants, 7 elephants (e.g., No. 1, 2, 3, 4, 5, 6 and 15) yielded clear MTBC infection positivity in the whole blood culture assays, consistent with the PBMCs for IGRA results (46.7% of total). In contrast, 8 elephants (e.g., No. 4, 8, and 10–15) were negative for the MTBC infection status (53.3% of total) based on the whole blood culture assays. All samples that yielded negative infection status showed consistent response to both TB1 and TB2 antigens. In contrast, elephants that showed MTBC infection-positive results exhibited contradictory responses in PBMC and WC cultures to ESAT6.

Next, to test the WC culture for IGRA in an elephant cohort with unknown MTBC infection status, we obtained blood samples from additional 9 elephants and the PBMC and WC cultures were performed in parallel. The concentrations of eIFN© obtained by the two approaches are shown in Fig 6A and the interpretation of the results are summarized in Fig 6B. Similar to the results from previous cohort, WC yielded higher concentrations of eIFN© than PBMC culture. Furthermore, all samples that yielded negative infection status have consistent negative responses in both WC and PBMC cultures (Fig 6A and 6B). In contrast, samples that were interpreted as MTBC positive exhibited conflicting responses to at least one M. tb antigens (No. 21, 22, 23, 24). These results strongly argue for the use of at least 2 M. tb antigens for IGRA. Taken together, whole blood cultures for IGRA provide a user-friendly platform with less amount of blood samples required to determine the MTBC infection status in elephants.

Fig 6. The eIFNγ concentrations obtained by PBMC cultures IGRA (PC) and whole blood cultures IGRA (WC) and summary of result interpretations in elephant cohort with unknown MTBC infection status.

Fig 6

(A) The results are presented as the eIFN© concentrations with comparisons between PBMC assays or whole blood culture assays at the individual level. The MTBC infection statuses were simplified to infection negative (green) or infection positive (red). (B) Nine elephant samples were subjected to PBMC cultures for IGRA in parallel with whole blood cultures for IGRA. The results obtained from each assay were interpreted based on the criteria described by Songthammaniphap et al. and above [12]. The interpretations are presented as a heatmap.

Discussion

TB infections in captive and wild elephants with severe outcomes have been increasingly reported and can be fatal [5, 21, 22]. Diagnosis of TB in elephants is a key step toward controlling the spread of this pathogen. Diagnostic tests not only help in veterinary care for the infected animals but also reduce the risk of human exposure to the pathogen because elephants sometimes live in close contact with humans in some parts of the world, including Thailand [20]. The gold standard for elephant TB diagnosis by using trunk wash cultures has many limitations, including difficulty in collecting samples and low sensitivity. Alternative methods for detection of active M. tb infection such as quantitative PCR (qPCR) or a highly sensitive droplet digital PCR (ddPCR) techniques have advantages over classical procedure for elephant TB diagnosis [23]. As in human TB diagnoses, IGRA presents an alternative method for diagnosing tuberculosis in elephants. Previously, IGRAs for elephant TB diagnosis have been reported and were demonstrated to be able to detect MTBC infections both in the latent and active disease stages [12, 17, 18].

In our previous study, we developed an IGRA to detect MTBC and NTM infections in Asian elephants in captivity who live in close proximity to humans in Thailand. The number of elephants subjected to IGRAs for TB diagnosis is the largest in the world to date. Tuberculosis is known to be transmitted from humans to animals, and elephant TB is shown to be transmitted back to humans in close contact [24]. IGRAs have widely been used for TB diagnosis in humans because of their sensitivity and ability to distinguish between BCG-vaccinated and TB-infected individuals. For animal TB, IGRA has been experimentally performed on wild and captive animals, but none are in routine use or commercially available [22]. The use of PBMCs in IGRAs has an advantage in normalizing the discrepancies in white blood cell numbers among individual elephants. The assay, however, requires laborious procedure of isolation of PBMCs and skilled laboratory personnel to work with relatively large volumes of blood. This study found that both PBMCs and whole blood cultures yielded similar interpretation of MTBC infection status and proposed the use of whole blood culture instead of PBMCs for IGRA in elephants.

Overall, stimulation of whole blood cultures by MTBC antigens yielded similar or higher levels of eIFN© production compared with those of PBMC cultures for IGRA. However, each elephant might respond to ESAT6 and CFP10 stimulation in PBMCs and whole blood cultures differently. For ESAT6 stimulation, 7 out of 24 samples showed discrepancies between PBMC and whole blood cultures. For CFP10, 3 out of 24 samples yielded contradictory results between the two approaches. CFP10 stimulation showed more consistent responses in MTBC infection positive elephants over ESAT6. Therefore, the use of at least two M. tb antigens are needed to obtain accurate interpretation of the infection status. In addition, combining the two antigens in one sample tube or using ESAT6-CFP10 fusion protein may provide a better approach for use in IGRAs using whole blood cultures [25].

On the attempt to simplify the IGRA method for elephant, we employed whole blood culture instead of PBMCs culture. In addition, omitting PPDA and PPDB used in previous study [12], and used only the defined recombinant proteins (e.g., ESAT6 and CFP10) to stimulate the recall response [26] in this streamline assay, make it possible to use blood volumes as small as 4 ml for each diagnostic test, in contrast to the 20 ml or greater volumes required for the PBMC isolation approach. Furthermore, the assay duration was shortened to 24 hr, as opposed to 72 hr with PBMCs.

Interestingly, suitable mitogens were tested as a positive control, and PWM was found to induce robust eIFN© production from whole blood cultures. This result is in line with a previous study where PWM and phorbol myristate acetate plus ionomycin induced high eIFN© production from whole blood cultures [17]. In a PBMC assay, ConA and PWM were found to induce similar levels of eIFN© production [12]. PWM has been known and used to stimulate T and B cells in humans and mice with mechanisms that are not well described [27]. Monocyte-depleted PBMCs are unresponsive to PWM stimulation, suggesting an important role of monocytes/macrophages [28]. ConA failed to stimulate whole blood cells to produce eIFN©even though it can robustly stimulate PBMCs. We speculate that the stimulation durations (e.g., 24 hr for whole blood culture vs. 72 hr for PBMC culture) may be responsible for the difference in eIFN© quantities.

Interpretation of the outcomes of IGRAs is also simplified to only MTBC infection negative or positive. Since crude antigens, PPDA and PPDB, representing NTM antigens and MTBC antigens, differentiation between MTBC and NTM infections may be possible if PPDA and PPDB are incorporated. However, NTM infections in theory are considered MTBC infection negative which usually have no clinical significance.

In the current study, WC for IGRA was first evaluated in an elephant cohort of 15 enrolled animals with previously known MTBC infection status using PBMC culture for IGRA. Because the gold standard for active elephant TB diagnosis is the trunk wash culture, we added elephant No.2 that has been previously diagnosed with TB infection by positive for both TB culture and PCR from trunk wash, and elephant No.1 that has been shown to have M. tb in trunk swab by ddPCR, as “true” positive control ([20] and S1 File). In addition, elephant No. 24 (cohort of 9 elephants) is also considered a “true positive of TB infection”, because it has been confirmed to have M. tb in trunk swab by ddPCR in this study (S1 File). The test for latent TB infection in elephants by IGRA have not been documented but the use of humoral immune indicator by detecting TB antigen specific immunoglobulins have been proposed [8]. The use of antibody detection may have advantage in monitoring response to treatment, but the level of antibody is dynamic and may decrease overtime after exposure to M. tb.

In conclusion, this study describes a novel platform that can diagnose MTBC infections using whole blood cultures. This approach has several advantages over PBMC for IGRA, including ease of sample preparation (user friendly), smaller blood volume collections and shorter times to diagnosis. The use of this method in a larger cohort of elephants will be needed to validate whether it is applicable for diagnosing MTBC infections in elephants.

Supporting information

S1 Table. List of elephants and the amounts of eIFNγ detected from PBMC culture.

(PDF)

S2 Table. List of elephants and the amounts of eIFNγ detected from whole blood culture.

(PDF)

S3 Table. List of elephants and the amounts of eIFNγ detected from mitogen stimulation.

(PDF)

S1 File. Detection of MTBC infection by droplet digital PCR (ddPCR).

(PDF)

Acknowledgments

The authors are grateful to all staffs at the Elephant Kingdom Project, Zoological Park Organization (under the Royal Patronage of His Majesty the King), Warangkhana Langkaphin (DVM) at the National Elephant Institute, Forest Industry Organization, Thailand, and Panida Muanghong (DVM) from the Thai Elephant Alliance, Thailand, for the collection of elephant samples.

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

This research was supported by the National Science and Technology Development Agency (grant number NSTDA: Project ID P-18-52114) awarded to WY. CP is supported by a Science Achievement Scholarship of Thailand (SAST) and the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund). TP is supported by the National Research Council of Thailand (grant number 811/2563).

References

  • 1.Montali RJ, Mikota SK, Cheng LI. Mycobacterium tuberculosis in zoo and wildlife species. Rev Sci Tech. 2001;20(1):291–303. doi: 10.20506/rst.20.1.1268 . [DOI] [PubMed] [Google Scholar]
  • 2.Michalak K, Austin C, Diesel S, Bacon MJ, Zimmerman P, Maslow JN. Mycobacterium tuberculosis infection as a zoonotic disease: transmission between humans and elephants. Emerg Infect Dis. 1998;4(2):283–7. Epub 1998/06/11. doi: 10.3201/eid0402.980217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Higgitt RL, Louis van Schalkwyk O, de Klerk-Lorist LM, Buss PE, Caldwell P, Rossouw L, et al. Mycobacterium bovis Infection in African Wild Dogs, Kruger National Park, South Africa. Emerg Infect Dis. 2019;25(7):1425–7. Epub 2019/06/19. doi: 10.3201/eid2507.181653 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chileshe J, Goosen WJ, Buss PE, van Helden PD, Warren R, Parsons SDC, et al. A commercial ELISA for detection of interferon gamma in white rhinoceros. J Vet Diagn Invest. 2019;31(4):531–6. Epub 2019/04/12. doi: 10.1177/1040638719843955 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Miller MA, Buss P, Roos EO, Hausler G, Dippenaar A, Mitchell E, et al. Fatal Tuberculosis in a Free-Ranging African Elephant and One Health Implications of Human Pathogens in Wildlife. Front Vet Sci. 2019;6:18. Epub 20190206. doi: 10.3389/fvets.2019.00018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Payeur JB, Jarnagin JL, Marquardt JG, Whipple DL. Mycobacterial isolations in captive elephants in the United States. Ann N Y Acad Sci. 2002;969:256–8. doi: 10.1111/j.1749-6632.2002.tb04388.x . [DOI] [PubMed] [Google Scholar]
  • 7.Mikota SK, Maslow JN. Tuberculosis at the human-animal interface: an emerging disease of elephants. Tuberculosis (Edinb). 2011;91(3):208–11. doi: 10.1016/j.tube.2011.02.007 . [DOI] [PubMed] [Google Scholar]
  • 8.Lyashchenko KP, Greenwald R, Esfandiari J, Olsen JH, Ball R, Dumonceaux G, et al. Tuberculosis in elephants: antibody responses to defined antigens of Mycobacterium tuberculosis, potential for early diagnosis, and monitoring of treatment. Clin Vaccine Immunol. 2006;13(7):722–32. doi: 10.1128/CVI.00133-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Greenwald R, Lyashchenko O, Esfandiari J, Miller M, Mikota S, Olsen JH, et al. Highly accurate antibody assays for early and rapid detection of tuberculosis in African and Asian elephants. Clin Vaccine Immunol. 2009;16(5):605–12. Epub 2009/03/06. doi: 10.1128/CVI.00038-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mikota SK, Peddie L, Peddie J, Isaza R, Dunker F, West G, et al. Epidemiology and diagnosis of Mycobacterium tuberculosis in captive Asian elephants (Elephas maximus). J Zoo Wildl Med. 2001;32(1):1–16. Epub 2003/06/07. doi: 10.1638/1042-7260(2001)032[0001:EADOMT]2.0.CO;2 . [DOI] [PubMed] [Google Scholar]
  • 11.Duncan AE, Lyashchenko K, Greenwald R, Miller M, Ball R. Application of Elephant TB STAT-PAK assay and MAPIA (multi-antigen print immunoassay) for detection of tuberculosis and monitoring of treatment in black rhinoceros (Diceros bicornis). J Zoo Wildl Med. 2009;40(4):781–5. doi: 10.1638/2009-0044.1 . [DOI] [PubMed] [Google Scholar]
  • 12.Songthammanuphap S, Puthong S, Pongma C, Buakeaw A, Prammananan T, Warit S, et al. Detection of Mycobacterium tuberculosis complex infection in Asian elephants (Elephas maximus) using an interferon gamma release assay in a captive elephant herd. Sci Rep. 2020;10(1):14551. Epub 20200903. doi: 10.1038/s41598-020-71099-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nature Reviews Microbiology. 2010;8(4):296–307. doi: 10.1038/nrmicro2321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev. 2008;226:191–204. Epub 2009/01/24. doi: 10.1111/j.1600-065X.2008.00702.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Arend SM, Geluk A, van Meijgaarden KE, van Dissel JT, Theisen M, Andersen P, et al. Antigenic equivalence of human T-cell responses toMycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infection and immunity. 2000;68(6):3314–21. doi: 10.1128/IAI.68.6.3314-3321.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Brock I, Weldingh K, Leyten EM, Arend SM, Ravn P, Andersen P. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. Journal of clinical microbiology. 2004;42(6):2379–87. doi: 10.1128/JCM.42.6.2379-2387.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Angkawanish T, Morar D, van Kooten P, Bontekoning I, Schreuder J, Maas M, et al. The elephant interferon gamma assay: a contribution to diagnosis of tuberculosis in elephants. Transbound Emerg Dis. 2013;60 Suppl 1:53–9. doi: 10.1111/tbed.12098 . [DOI] [PubMed] [Google Scholar]
  • 18.Paudel S, Villanueva MA, Mikota SK, Nakajima C, Gairhe KP, Subedi S, et al. Development and evaluation of an interferon-gamma release assay in Asian elephants (Elephas maximus). J Vet Med Sci. 2016;78(7):1117–21. doi: 10.1292/jvms.15-0701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yindeeyoungyeon W, Rukseree K, Tungsudjai S, Panichakul T. Evaluation of Recombinant Mycobacterium tuberculosis Antigens MPT64, CFP10, and ESAT6 for Delayed-Type Hypersensitivity Responses in Guinea Pigs. Adv Microbiol 2015;5(8):586–98. doi: 10.4236/aim.2015.58061 [DOI] [Google Scholar]
  • 20.Angkawanish T, Wajjwalku W, Sirimalaisuwan A, Mahasawangkul S, Kaewsakhorn T, Boonsri K, et al. Mycobacterium tuberculosis infection of domesticated Asian elephants, Thailand. Emerg Infect Dis. 2010;16(12):1949–51. doi: 10.3201/eid1612.100862 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ong BL, Ngeow YF, Razak MF, Yakubu Y, Zakaria Z, Mutalib AR, et al. Tuberculosis in captive Asian elephants (Elephas maximus) in Peninsular Malaysia. Epidemiol Infect. 2013;141(7):1481–7. doi: 10.1017/S0950268813000265 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Maslow JN, Mikota SK. Tuberculosis in elephants-a reemergent disease: diagnostic dilemmas, the natural history of infection, and new immunological tools. Vet Pathol. 2015;52(3):437–40. doi: 10.1177/0300985814568357 . [DOI] [PubMed] [Google Scholar]
  • 23.Ushio R, Yamamoto M, Nakashima K, Watanabe H, Nagai K, Shibata Y, et al. Digital PCR assay detection of circulating Mycobacterium tuberculosis DNA in pulmonary tuberculosis patient plasma. Tuberculosis (Edinb). 2016;99:47–53. Epub 20160415. doi: 10.1016/j.tube.2016.04.004 . [DOI] [PubMed] [Google Scholar]
  • 24.Waters WR, Maggioli MF, McGill JL, Lyashchenko KP, Palmer MV. Relevance of bovine tuberculosis research to the understanding of human disease: historical perspectives, approaches, and immunologic mechanisms. Vet Immunol Immunopathol. 2014;159(3–4):113–32. doi: 10.1016/j.vetimm.2014.02.009 . [DOI] [PubMed] [Google Scholar]
  • 25.van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol. 2000;7(2):155–60. doi: 10.1128/CDLI.7.2.155-160.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Waters WR, Palmer MV, Thacker TC, Payeur JB, Harris NB, Minion FC, et al. Immune responses to defined antigens of Mycobacterium bovis in cattle experimentally infected with Mycobacterium kansasii. Clin Vaccine Immunol. 2006;13(6):611–9. doi: 10.1128/CVI.00054-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wallays G, Ceuppens JL. Human T lymphocyte activation by pokeweed mitogen induces production of TNF-alpha and GM-CSF and helper signaling by IL-1 and IL-6 results in IL-2-dependent T cell growth. Eur Cytokine Netw. 1993;4(4):269–77. . [PubMed] [Google Scholar]
  • 28.Rosenberg SA, Lipsky PE. The role of monocytes in pokeweed mitogen-stimulated human B cell activation: separate requirements for intact monocytes and a soluble monocyte factor. J Immunol. 1981;126(4):1341–5. . [PubMed] [Google Scholar]

Decision Letter 0

Harish Chandra

20 Jun 2023

Using Whole Blood Cultures in Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Complex Infection in Asian Elephants (Elephas maximus)

PONE-D-23-08890

Dear Dr. anapat Palaga,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Harish Chandra, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“WY was supported by the National Science and Technology Development Agency (NSTDA: Project ID P-18-52114). CP is supported by a Science Achievement Scholarship of Thailand (SAST). TP is supported by the National Research Council of Thailand.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please respond by return e-mail so that we can amend your financial disclosure and competing interests on your behalf.

3. We note that Figure 3 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 3 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b.If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Additional Editor Comments (optional):

Using Whole Blood Cultures in Interferon Gamma Release Assays to Detect Mycobacterium Tuberculosis Complex Infection in Asian Elephants (Elephas maximus)" By Tanapat Palaga is well-written and scientifically sound. Further, the manuscript meets our publication criteria of ‘experiments, statistics and other analyses are performed well to a high technical standard and are described in sufficient detail’ and ‘conclusions are presented in an appropriate fashion that is supported by the data’. As an editor and reviewer, I feel the manuscript is fit for publication.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: It's a very interesting study, because it's a very unknow theme for a doctors. The new technological ways used with the IGRAS and the use of a whool blodd culture seems a very interestin procedure. Wood and beautifool work.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Harish Chandra

18 Jul 2023

PONE-D-23-08890

Using Whole Blood Cultures in Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Complex Infection in Asian Elephants (Elephas maximus)

Dear Dr. Palaga:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Harish Chandra

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. List of elephants and the amounts of eIFNγ detected from PBMC culture.

    (PDF)

    S2 Table. List of elephants and the amounts of eIFNγ detected from whole blood culture.

    (PDF)

    S3 Table. List of elephants and the amounts of eIFNγ detected from mitogen stimulation.

    (PDF)

    S1 File. Detection of MTBC infection by droplet digital PCR (ddPCR).

    (PDF)

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES